SUMMARY

Discontinuation of CADD-Legacy Pumps

• ICU Medical is discontinuing the sale of CADD^TM-Legacy PCA (model 6300), CADD^TM-Legacy 1 (model 6400), and CADD^TM-Legacy Plus (model 6500) ambulatory infusion pumps and CADD Sentry Medication Delivery Manager Software effective December 31, 2022.¹
  • Service and repair for these products will be available through December 31, 2027 depending on component availability.

CADD-Solis VIP pumps

• ICU Medical has developed the CADD^®-Solis VIP pumps to meet the needs of customers and the healthcare industry. Patients have transitioned from the CADD^TM-Legacy to the CADD^®-Solis pumps for more than ten years.¹
  • The CADD-Legacy pump could achieve rates up to 125 mL/hr. The CADD-Solis VIP pump can achieve rates up to 250 mL/hr with standard flow sets and rates up to 500 mL/hr with high flow sets. The rates also depend upon the therapy mode set on the VIP.²
  • The CADD-Legacy pump was programmed in mL/24 hr and the CADD-Solis VIP pump rate is programmed in mL/h.²
  • The CADD-Solis platform includes additional options including protocol libraries, wireless connectivity, and five delivery modes.¹
• Questions regarding the CADD^®-Solis VIP pump, including requests for device training, should be emailed to [email protected].²
  • Inquiries and requests sent to this inbox will be addressed within 24 hours. If a brochure or instruction can address the question, it will be provided.
  • If additional information is needed, Smiths Medical will contact the healthcare provider to address questions with one of their live support staff.

VELETRI infusion pump

• The ambulatory infusion pump used to administer VELETRI should: 1) be small and lightweight, 2) be able to adjust infusion rates in 2-ng/kg/min increments, 3) have occlusion, end-of-infusion, and low-battery alarms, 4) be accurate to ±6% of the programmed rate, and 5) be positive pressure-driven (continuous or pulsatile) with intervals between pulses not exceeding 3 minutes at infusion rates used to deliver VELETRI. The reservoir should be made of polyvinyl chloride, polypropylene, or glass.³

Issues Notice for CADD Infusion System Infusion Sets

• In December 2022, Smiths Medical issued a letter notifying of two potential issues with CADD^TM Infusion System Infusion Sets. Then, on February 2, 2023, the FDA identified this as a Class I recall; the recall communication is available on the FDA website.⁴ In June 2023, Smiths Medical issued an updated notice to the December 2022 letter, stating that additional lots may potentially be impacted by the 2 issues described below.⁵
  • Issue 1: Lack of delivery or underdelivery related to tubing occlusion, despite the pump displaying that the infusion is running properly.
  • Issue 2: False “No Disposable Attached (NDA)” alarms.
• For certain patient situations, use of alternative CADD infusion sets may be recommended. Customers may also contact Smiths Medical customer service (1-800-258-5361).